Arkeon Bio is a biotechnology company that captures CO2 from industry and converts inorganic gases into organic food.
Arkeon Biotechnologies has raised $4.3M in total funding. The most recent round was Seed. The last funding was announced in December 2022.
Arkeon Biotechnologies's investors include aws Gründungsfonds, Synthesis Capital, ReGen Ventures, HackCapital, Tet Ventures.
Arkeon Biotechnologies is headquartered in Tulln, Austria.
Arkeon Bio is a biotechnology company that captures CO2 from industry and converts inorganic gases into organic food.
Arkeon Biotechnologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arkeon Biotechnologies — Funding & Investors." VCBacked, December 23, 2022, https://www.vcbacked.co/company/arkeon-biotechnologies. Accessed August 14, 2026.
VCBacked. (2022). Arkeon Biotechnologies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/arkeon-biotechnologies
{{cite web |title=Arkeon Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/arkeon-biotechnologies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated